Research suggests SARS-CoV-2 vaccine circulation strategy with a focus on where virus spreads more easily
.jpg?fit=300%2C300&ssl=1 "Cyclic RNA vaccine shows neutral activity against B.1.351 variant")
.jpg?fit=300%2C300&ssl=1 "ChAdOx1 nCoV-19 vaccine does not protect against South African SARS-CoV-2 variant")
-1.jpg?fit=300%2C300&ssl=1 "Development of a COVID-19 vaccine using inactivated E. coli")
.jpg?fit=300%2C300&ssl=1 "A new variable may not have altered the COVID-19 pandemic course in the UK, a study says")
.jpg?fit=300%2C300&ssl=1 "A new study maps SARS-CoV-2 and hosts protein interactions")